Fingerprint
Dive into the research topics of 'An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically